Common use of Incorporators, Stockholders, Members Clause in Contracts

Incorporators, Stockholders, Members. Officers, Directors and Employees of Issuer and Guarantor Exempt from Individual Liability 33 Section 10.02 Provisions of Indenture for the Sole Benefit of Parties and Securityholders 33 Section 10.03 Successors and Assigns of Issuer and Guarantor Bound by Indenture 33 Section 10.04 Notices and Demands on Issuer, Trustee and Securityholders 33 Section 10.05 Officer’s Certificates and Opinions of Counsel; Statements to be Contained Therein 35 Section 10.06 Payments Due on Saturdays, Sundays and Holidays 35 Section 10.07 Conflict of any Provision of Indenture with Trust Indenture Act of 1939 36 Section 10.08 New York Law to Govern 36 Section 10.09 Counterparts 36 Section 10.10 Effect of Headings 36 Section 10.11 Securities in a Non-U.S. Currency 36 Section 10.12 Submission to Jurisdiction 36 Section 10.13 Judgment Currency 36 Section 10.14 Waiver of Jury Trial 37 Section 10.15 Foreign Account Tax Compliance Act 37 Section 11.01 Applicability of Article 37 Section 11.02 Notice of Redemption; Partial Redemptions 37 Section 11.03 Payment of Securities Called for Redemption 38 Section 11.04 Exclusion of Certain Securities from Eligibility for Selection for Redemption 38 Section 11.05 Mandatory and Optional Sinking Funds 39 Section 12.01 The Guarantee 40 Section 12.02 Net Payments 40 Section 12.03 Guarantee Unconditional, etc. 41 Section 12.04 Reinstatement 42 Section 12.05 Subrogation 42 Section 12.06 Assumption by Guarantor 42 THIS INDENTURE, dated as of March 14, 2018, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),

Incorporators, Stockholders, Members. Officers, Officers and Directors and Employees of Issuer and Guarantor Exempt from Individual Liability 33 30 Section 10.02 10.02. Provisions of Indenture for the Sole Benefit of Parties and Securityholders 33 30 Section 10.03 10.03. Successors and Assigns of Issuer and Guarantor Bound by Indenture 33 30 Section 10.04 10.04. Notices and Demands on Issuer, Trustee and Securityholders 33 30 Section 10.05 Officer’s 10.05. Officers’ Certificates and Opinions of Counsel; Statements to be Contained Therein 35 32 Section 10.06 10.06. Payments Due on Saturdays, Sundays and Holidays 35 32 Section 10.07 10.07. Conflict of any Provision of Indenture with Trust Indenture Act of 1939 36 33 Section 10.08 10.08. New York Law to Govern 36 33 Section 10.09 10.09. Counterparts 36 33 Section 10.10 10.10. Effect of Headings 36 33 Section 10.11 10.11. Securities in a Non-U.S. Currency 36 33 Section 10.12 10.12. Submission to Jurisdiction 36 33 Section 10.13 10.13. Judgment Currency 36 33 Section 10.14 10.14. Waiver of Jury Trial 37 34 Section 10.15 10.15. Foreign Account Tax Compliance Act 37 34 Section 11.01 11.01. Applicability of Article 37 34 Section 11.02 11.02. Notice of Redemption; Partial Redemptions 37 34 Section 11.03 11.03. Payment of Securities Called for Redemption 38 35 Section 11.04 11.04. Exclusion of Certain Securities from Eligibility for Selection for Redemption 38 35 Section 11.05 11.05. Mandatory and Optional Sinking Funds 39 Section 12.01 The Guarantee 40 Section 12.02 Net Payments 40 Section 12.03 Guarantee Unconditional, etc. 41 Section 12.04 Reinstatement 42 Section 12.05 Subrogation 42 Section 12.06 Assumption by Guarantor 42 THIS INDENTURE, dated as of March 14, 2018, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),35

Incorporators, Stockholders, Members. Officers, Directors and Employees of Issuer and Guarantor Exempt from Individual Liability 33 Section 10.02 Provisions of Indenture for the Sole Benefit of Parties and Securityholders 33 Section 10.03 Successors and Assigns of Issuer and Guarantor Bound by Indenture 33 Section 10.04 Notices and Demands on Issuer, Trustee and Securityholders 33 Section 10.05 Officer’s Certificates and Opinions of Counsel; Statements to be Contained Therein 35 Section 10.06 Payments Due on Saturdays, Sundays and Holidays 35 Section 10.07 Conflict of any Provision of Indenture with Trust Indenture Act of 1939 36 35 Section 10.08 New York Law to Govern 36 Section 10.09 Counterparts 36 Section 10.10 Effect of Headings 36 Section 10.11 Securities in a Non-U.S. Currency 36 Section 10.12 Submission to Jurisdiction 36 Section 10.13 Judgment Currency 36 Section 10.14 Waiver of Jury Trial 37 Section 10.15 Foreign Account Tax Compliance Act 37 Section 11.01 Applicability of Article 37 Section 11.02 Notice of Redemption; Partial Redemptions 37 Section 11.03 Payment of Securities Called for Redemption 38 Section 11.04 Exclusion of Certain Securities from Eligibility for Selection for Redemption 38 Section 11.05 Mandatory and Optional Sinking Funds 39 Section 12.01 The Guarantee 40 Section 12.02 Net Payments 40 Section 12.03 Guarantee Unconditional, etc. 41 Section 12.04 Reinstatement 42 41 Section 12.05 Subrogation 42 41 Section 12.06 Assumption by Guarantor 42 THIS INDENTURE, dated as of March 14, 2018, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),

Incorporators, Stockholders, Members. Officers, Directors and Employees of Issuer and Guarantor Exempt from Individual Liability 33 Section 10.02 Provisions of Indenture for the Sole Benefit of Parties and Securityholders 33 Section 10.03 Successors and Assigns of Issuer and Guarantor Bound by Indenture 33 Section 10.04 Notices and Demands on Issuer, Trustee and Securityholders 33 Section 10.05 Officer’s Certificates and Opinions of Counsel; Statements to be Contained Therein 35 Section 10.06 Payments Due on Saturdays, Sundays and Holidays 35 Section 10.07 Conflict of any Provision of Indenture with Trust Indenture Act of 1939 36 Section 10.08 New York Law to Govern 36 Section 10.09 Counterparts 36 Section 10.10 Effect of Headings 36 Section 10.11 Securities in a Non-U.S. Currency 36 Section 10.12 Submission to Jurisdiction 36 Section 10.13 Judgment Currency 36 Section 10.14 Waiver of Jury Trial 37 Section 10.15 Foreign Account Tax Compliance Act 37 Section 11.01 Applicability of Article 37 Section 11.02 Notice of Redemption; Partial Redemptions 37 Section 11.03 Payment of Securities Called for Redemption 38 Section 11.04 Exclusion of Certain Securities from Eligibility for Selection for Redemption 38 Section 11.05 Mandatory and Optional Sinking Funds 39 Section 12.01 The Guarantee 40 Section 12.02 Net Payments 40 Section 12.03 Guarantee Unconditional, etc. 41 Section 12.04 Reinstatement 42 Section 12.05 Subrogation 42 Section 12.06 Assumption by Guarantor 42 THIS INDENTURE, dated as of March 14, 2018, by and among Teva Pharmaceutical Finance Netherlands II III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),

Incorporators, Stockholders, Members. Officers, Officers and Directors and Employees of Issuer and Guarantor Exempt from Individual Liability 33 41 Section 10.02 9.04. Provisions of Indenture for the Sole Benefit of Parties and Securityholders 33 Noteholders 42 Section 10.03 9.05. Successors and Assigns of Issuer and Guarantor Bound by Indenture 33 42 Section 10.04 9.06. Notices and Demands on Issuer, Trustee and Securityholders 33 Noteholders 42 Section 10.05 9.07. Officer’s Certificates and Opinions of Counsel; Statements to be Contained Therein 35 43 Section 10.06 9.08. Payments Due on Saturdays, Sundays and Holidays 35 44 Section 10.07 9.09. Conflict of any Provision of Indenture with Trust Indenture Act of 1939 36 TIA 44 Section 10.08 9.10. New York Law to Govern 36 44 Section 10.09 9.11. Counterparts 36 44 Section 10.10 9.12. Effect of Headings 36 45 Section 10.11 Securities in a Non-U.S. Currency 36 Section 10.12 9.13. Submission to Jurisdiction 36 45 Section 10.13 Judgment 9.14. Currency 36 Indemnity 45 Section 10.14 Waiver of Jury Trial 37 10.01. At Maturity 46 Section 10.15 Foreign Account 10.02. Redemption for Tax Compliance Act 37 Reasons 46 Section 11.01 Applicability of Article 37 10.03. Purchases 47 Section 11.02 10.04. Cancellation 47 Section 10.05. Notice of Redemption; Partial Redemptions 37 Redemption 47 Section 11.03 10.06. Payment of Securities Subordinated Notes Called for Redemption 38 48 Section 11.04 Exclusion 11.01. Agreement to Subordinate 48 Section 11.02. Payments To Noteholders 49 Section 11.03. No Payment When Senior Debt is in Default 50 Section 11.04. Payment Permitted in Certain Situations 50 Section 11.05. Subrogation to Rights of Certain Securities from Eligibility Holders of Senior Debt 51 Section 11.06. Provisions Solely to Define Relative Rights 51 Section 11.07. Trustee to Effectuate Subordination 52 Section 11.08. No Waiver of Subordination Provisions 52 Section 11.09. Notice to Trustee 52 Section 11.10. Reliance on Judicial Order or Certificate of Liquidating Agent 52 Section 11.11. Trustee Not Fiduciary for Selection Holders of Senior Debt 53 Section 11.12. Rights of Trustee as Holder of Senior Debt; Preservation of Trustee’s Rights 53 Section 11.13. Article Applicable to Paying Agents. 53 SCHEDULE 1 Terms and Conditions of the Subordinated Notes S1-1 SCHEDULE 2 Form and Transfer of Subordinated Notes S2-1 Part I – Form of Rule 144A Global Note S2-1 Part II – Form of Regulation S Global Note I S2-7 Part III – Form of Definitive Note S2-13 Part IV – Register, Transfer and Exchange of Subordinated Notes S2-19 Part V – Form of Transfer Letters S2-21 SCHEDULE 3 Provisions for Redemption 38 Section 11.05 Mandatory and Optional Sinking Funds 39 Section 12.01 The Guarantee 40 Section 12.02 Net Payments 40 Section 12.03 Guarantee Unconditional, etc. 41 Section 12.04 Reinstatement 42 Section 12.05 Subrogation 42 Section 12.06 Assumption by Guarantor 42 THIS Meetings of Noteholders S3-1 INDENTURE, dated as of March 14June 2, 2018, by and among Teva Pharmaceutical Finance Netherlands II B.V.2003 between ABN AMRO Bank N.V., a private company with public limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation company incorporated under the laws of Israel The Netherlands (the “GuarantorIssuer”), and The Bank of New York MellonYork, a New York banking corporation corporation, as trustee (the “Trustee”),.